The Pharmacological Mechanism of the Effect of Plant Extract Compound Drugs on Cancer Pain Based on Network Pharmacology

Yuanyuan Shen, Jun Wang, Pengpeng Yan, Tiantian Chen, Xingrui Li, Ming JiangJournal of Healthcare Engineering 2022 · DOI

TL;DR

This study uses network pharmacology to explore how plant-derived compound drugs alleviate cancer pain. By analyzing active ingredients, their targets, and disease pathways, the researchers identified key targets and signaling pathways involved in pain relief, suggesting a promising therapeutic avenue for botanical medicines.

What Problem Does This Paper Address?

Cancer pain is a significant and complex issue affecting a large proportion of cancer patients, severely impacting their quality of life. While Western medicine offers pain relief, it often comes with issues like addiction and tolerance. Traditional Chinese Medicine (TCM) has a long history of treating pain, but its mechanisms are not fully understood. This paper aims to bridge this gap by using network pharmacology to systematically investigate the pharmacological mechanisms of plant-derived compound drugs in alleviating cancer pain, offering a more comprehensive understanding beyond single-compound, single-target approaches.

Methods

The researchers employed a network pharmacology approach, which involves integrating multiple databases and analytical tools to understand complex biological systems. The key steps included:

  • Active Ingredient Identification: Mining databases like TCMSP, ETCM, and TCMID to identify active compounds from 11 selected plant-derived drugs.
  • Target Prediction: Using databases such as TCMSP, PharmMapper, and SwissTarget to predict the protein targets associated with these active ingredients.
  • Disease Target Identification: Searching OMIM, GeneCards, and DrugBank databases for genes and proteins implicated in cancer pain.
  • Network Construction: Building a "compound-target-disease" network and a protein-protein interaction (PPI) network using Cytoscape software and the STRING database to visualize relationships and identify core targets.
  • Enrichment Analysis: Performing Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses using DAVID and Metascape platforms to understand the biological processes, molecular functions, cellular components, and signaling pathways involved in cancer pain relief.

Datasets

The study utilized several publicly available databases:

  • Traditional Chinese Medicine Databases: TCMSP (Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform), ETCM (The Encyclopedia of Traditional Chinese Medicine), and TCMID (Traditional Chinese Medicine Integrated Database).
  • Target Prediction Databases: PharmMapper, SwissTarget.
  • Human Protein Databases: UniProt.
  • Disease Target Databases: OMIM (Online Mendelian Inheritance in Man), GeneCards, and DrugBank.
  • Network Analysis Tools: STRING database and Cytoscape software.
  • Enrichment Analysis Platforms: DAVID and Metascape.

No new datasets were introduced in this study.

Key Insights and Ideas

  • Multi-Target Approach: Network pharmacology allows for a holistic view, moving beyond single-target drug discovery to understand how multiple compounds from botanical medicines interact with various targets to achieve a therapeutic effect.
  • Identification of Core Targets: The study successfully pinpointed 19 core targets, including key players like TNF, MAPK1, JUN, and IL-6, which are crucial for the analgesic effects of these plant-derived drugs. This provides specific molecular targets for further investigation.
  • Pathway Involvement: The analysis revealed that plant-derived drugs for cancer pain primarily engage in 193 biological processes, 47 molecular functions, and 22 cell components, with a significant focus on 118 signaling pathways.
  • Key Signaling Pathways: The PI3K-Akt, tumor necrosis factor, MAPK, Toll-like receptor, and HIF-1 signaling pathways were identified as central to the pain-relieving mechanisms of these botanical drugs. This highlights specific molecular cascades that could be modulated for therapeutic benefit.
  • Inflammatory and Apoptotic Modulation: The findings suggest that botanical drugs can positively influence the expression of inflammatory and apoptotic factors, which are critical in both the development and resolution of cancer pain.

Key Results

  • Active Ingredients and Targets: A total of 153 active ingredients from 11 botanical drugs were identified, which correspond to 341 protein targets in the human body.
  • Common Targets: After cross-referencing with cancer pain-related targets from OMIM, GeneCards, and DrugBank, 141 common targets were identified between plant-derived drugs and cancer pain.
  • Core Targets: Through PPI network analysis, 19 core targets were screened, with TNF, MAPK1, JUN, and IL-6 being highlighted as particularly important.
  • Enrichment Analysis: GO enrichment identified 193 biological processes, 47 molecular functions, and 22 cell components. KEGG analysis revealed 118 signaling pathways, with PI3K-Akt, TNF, MAPK, Toll-like receptor, and HIF-1 signaling pathways being most prominent.

Limitations and Future Work

  • Data Completeness: The authors acknowledge that the data from TCMSP and other databases may not be entirely complete. They suggest that future work should involve more advanced techniques like UPLC, UPLC-Q-TOF-MS to obtain more comprehensive chemical information.
  • Experimental Validation: While this study provides a theoretical framework, experimental validation of the identified targets and pathways is crucial to confirm the proposed mechanisms and therapeutic effects.
  • Clinical Translation: Further research is needed to translate these findings into clinical applications, potentially leading to the development of novel botanical drug-based therapies for cancer pain management.

Summary updated

Abstract

These results indicate that botanical drugs can positively affect the expression of inflammatory factors and apoptotic factors in the process of treatment and relief of cancer pain, which is expected to have a potential therapeutic effect on the relief of cancer pain.
BibTeX
@article{shen2022pharmacological,
  author = {Yuanyuan Shen and Jun Wang and Pengpeng Yan and Tiantian Chen and Xingrui Li and Ming Jiang},
  title = {{The Pharmacological Mechanism of the Effect of Plant Extract Compound Drugs on Cancer Pain Based on Network Pharmacology}},
  journal = {Journal of Healthcare Engineering},
  year = {2022},
  doi = {10.1155/2022/9326373},
}
Figure